Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma-Reference-Cited by-同舟云学术

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Published:2012-08-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vale Claire L¹,Tierney Jayne¹,Bull Sarah J²,Symonds Paul R³

Affiliation:

1. MRC Clinical Trials Unit at UCL; Meta-analysis Group; Aviation House 125 Kingsway London UK WC2B 6SE

2. MRC Clinical Trials Unit; Meta-analysis Group; Aviation House 125 Kingsway London UK WC2B 6SE

3. Leicester Royal Infirmary; Department of Oncology; Leicester UK LE1 5WW

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003915.pub4/fullpdf

Reference40 articles.

1. Aapro M Bolis G Chevallier B van der Burg MEL Poveda A de Oliveira C An EORTC-GCCG randomized phase II trial of doxorubicin versus dox-cisplatin (cDDP) in endometrial carcinoma Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1994 275

2. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC-GCCG;Aapro;Annals of Oncology,2003

3. Multidrug treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study;Cohen;Obstetrics and Gynecology,1984

4. Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma;Edmonson;Gynecologic Oncology,1987

5. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study;Fleming;Journal of Clinical Oncology,2004

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential prognostic predictors of treatment with immune checkpoint inhibitors for advanced endometrial cancer;Japanese Journal of Clinical Oncology;2024-09-03

2. The role of miR-765 in human cancers;International Immunopharmacology;2024-09

3. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

4. CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancer;Cellular Signalling;2024-05

5. Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States;Journal of Health Economics and Outcomes Research;2023-11-08